Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Drug-Coated Balloons Market Growth in 2025?

In recent times, the market size of drug-coated balloons has seen considerable expansion. The forecast suggests an upward trend from $1.08 billion in 2024 to $1.24 billion in 2025, indicating a compound annual growth rate (CAGR) of 15.4%. The significant growth observed in the past has been driven by factors such as a rising incidence of cardiovascular disease, the need for less invasive procedures, a higher prevalence of peripheral artery disease (pad), lowering rates of restenosis, and advancements in the field of interventional cardiology.

What Is the Forecast for the Drug-Coated Balloons Market Size Through 2029?

Expectations are high for the drug-coated balloons market to experience accelerated growth in the coming years, with projections pointing to a valuation of “$2.22 billion by 2029, and a compound annual growth rate (CAGR) of 15.6%. The substantial increase predicted within the forecast period can be linked to a thriving older population, the widening scope of indications and applications, an emphasis on outpatient and ambulatory care, the merging with innovative drug delivery solutions, and international health initiatives. Key trends anticipated during the forecast period involve receiving regulatory authorization for new mixtures, a focus on reducing adverse side effects, the rise of bioresorbable coatings, burgeoning markets within emerging economies, and a move towards patient-centric strategies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

What are the Key Market Players in Drug-Coated Balloons Market and How They’re Evolving?

Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

What Are the Primary Growth Drivers in the Drug-Coated Balloons Market?

The anticipated increase in incidents of coronary artery disease (CAD) is believed to drive the expansion of the drug-coated balloon market. CAD, a medical condition characterized by the narrowing or blockage of coronary arteries that supply blood to the heart muscle, can result in heart attacks. The drug-coated balloon is a therapeutic device employed in the treatment of CAD. The drug contained within the balloon is dispensed into the artery during the procedure to deter restenosis, or the re-narrowing of the artery post-angioplasty. For instance, a study published by a US-based organization in the Journal of the American College of Cardiology in August 2022 indicated that all four cardiovascular risk factors are predicted to increase in the general U.S. population from 2025 to 2060. Diabetes is projected to see the largest percentage increase of 39.3%, followed by dyslipidemia at 27.6%, hypertension at 25.1%, and obesity at 18.3%. The study found that heart failure (33.4%) and ischemic heart disease (30.7%) are the conditions with the largest projected increases, followed by heart attack (16.9%) and stroke (33.8%). Hence, the anticipated rise in CAD cases is projected to stimulate the growth of the drug-coated balloon market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10829&type=smp

What Are the Leading Segments in the Global Drug-Coated Balloons Industry?

The drug-coated balloons market covered in this report is segmented –

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications

2) By Drug Type: Paclitaxel, Sirolimus

3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Subsegments:

1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons

2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Everolimus-Coated Balloons

3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions, Drug-Coated Balloons For Renal Artery Lesions, Drug-Coated Balloons For Other Vascular Applications

What Are the Key Market Trends in the Drug-Coated Balloons Industry?

A prevalent trend in the drug-coated balloon market is product innovation. To solidify their standing in the market, dominant firms are concentrating on creating novel and cutting-edge solutions. As an example, Becton, Dickinson, and Company (BD), an American medical technology firm, initiated the PREVISION first-of-its-kind trial in August 2022 for a peripheral sirolimus drug-coated balloon (DCB). The goal of this trial is to evaluate the effectiveness and safety of the sirolimus DCB in treating those suffering from peripheral artery disease, a disorder that greatly affects movement and the standard of living.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

What Is the Regional Outlook for the Drug-Coated Balloons Market?

North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10829

This Report Delivers Insight On:

1. How big is the drug-coated balloons market, and how is it changing globally?

2. Who are the major companies in the drug-coated balloons market, and how are they performing?

3. What are the key opportunities and risks in the drug-coated balloons market right now?

4. Which products or customer segments are growing the most in the drug-coated balloons market?

5. What factors are helping or slowing down the growth of the drug-coated balloons market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model